Target intelligence / Profile preview

Troponin I type 1 (skeletal, slow) (TNNI1)

Target
TNNI1
Molecular classification
Structural protein, Myofilament protein, Component of contractile apparatus, Other
01

Overview

Troponin I type 1 (skeletal, slow) is a muscle-specific regulatory protein encoded by the TNNI1 gene and predominately expressed in slow-twitch skeletal muscle fibers. It is one of three subunits of the troponin complex, where it serves as the inhibitory component that prevents actin-myosin interactions, thus regulating contraction and relaxation through its calcium-dependent conformational change[1][2]. TNNI1 is essential for normal muscle function, fine-tuning the calcium sensitivity of force development. Pathogenic variants cause a spectrum of myopathies, with loss-of-function mutations leading to muscle weakness, and gain-of-function mutations associated with hypercontractile symptoms[3]. TNNI1 can serve as a specific biomarker for slow-twitch muscle injury and has attracted experimental therapeutic research, but it is not classified as a conventional drug target like a receptor or enzyme[1][2][3].

Other names
Troponin I, slow skeletal muscleTNN1ssTnITroponin I, slow-twitch isoformSSTNItroponin I slow skeletal muscle isoformtroponin I type 1 (skeletal, slow)
02

Mechanism of action

Activators: Increase contractility by sensitizing the troponin complex to calcium (for loss-of-function TNNI1 variants); Inhibitors: Reduce excessive contractility by inhibiting myosin activity (for gain-of-function TNNI1 variants)

03

Biological functions

Regulation of muscle contraction and relaxationInhibition of actin-myosin interactionModulation of calcium sensitivity in slow-twitch skeletal muscle fibers
04

Disease associations

Muscle disease (myopathy) due to pathogenic variantsBiomarker for skeletal muscle injury and slow fiber damageOther
05

Safety considerations

Alterations in TNNI1 function can cause either hypo- or hypercontractile muscle disorders, so therapeutic intervention requires precision to avoid exacerbating contraction defects
06

Interacting drugs

Slow skeletal muscle troponin activator (used experimentally for loss-of-function TNNI1 variants)

1 more in the full profile.

07

Biomarkers

Slow skeletal troponin I protein (for detecting slow-twitch muscle fiber damage and myopathies)

Beyond the preview

Go deeper on Troponin I type 1 (skeletal, slow) (TNNI1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Troponin I type 1 (skeletal, slow) (TNNI1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call